Variables | Median survival time (days) | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||
Gender (male/female) | 170/255 | 0.668 | 0.362–1.234 | 0.198 | 1.289 | 0.628–2.644 | 0.489 |
Age (years) | 1.005 | 0.985–1.026 | 0.603 | 0.992 | 0.970–1.016 | 0.517 | |
LTS (cm) | 1.074 | 1.025–1.126 | 0.003 | 1.086 | 1.021–1.154 | 0.008 | |
BCLC (A + B/C) | 239/59 | 2.798 | 1.748–4.481 | < 0.001 | 1.095 | 1.076–3.372 | 0.027 |
Treatment at rupture | |||||||
Conservative (control) | 48 | – | – | – | – | – | – |
TAE/TACE | 159 | 0.565 | 0.334–0.956 | 0.033 | 0.660 | 0.354–1.231 | 0.192 |
Hepatectomy | 466 | 0.202 | 0.105–0.388 | < 0.001 | 0.180 | 0.076–0.427 | < 0.001 |
Blood transfusion (no/yes) | 160/381 | 0.495 | 0.287–0.854 | 0.012 | 1.053 | 0.540–2.052 | 0.880 |
Viral hepatitis (none/HBV + HCV) | 184/172 | 0.977 | 0.530–1.803 | 0.941 | |||
Cirrhosis (no/yes) | 207/168 | 1.394 | 0.783–2.482 | 0.259 | |||
AFP (≤400/> 400) | 1.549 | 0.994–2.412 | 0.053 | ||||
WBC (×109/L) | 0.992 | 0.953–1.032 | 0.686 | ||||
HB (g/L) | 0.998 | 0.989–1.007 | 0.642 | ||||
PT (s) | 1.137 | 1.056–1.224 | 0.001 | 0.994 | 0.845–1.055 | 0.312 | |
ALB (g/L) | 0.959 | 0.932–0.988 | 0.005 | 0.944 | 0.905–0.984 | 0.007 | |
TBil (umol/L) | 1.015 | 1.008–1.021 | < 0.001 | 1.021 | 1.010–1.032 | < 0.001 | |
Na+ (mmol/L) | 0.945 | 0.892–1.000 | 0.049 | 1.040 | 0.971–1.113 | 0.266 | |
SCr (umol/L) | 1.003 | 0.998–1.009 | 0.213 | ||||
TACE during follow-up (no/yes) | 92/347 | 0.420 | 0.255–0.692 | 0.001 | 0.414 | 0.233–0.737 | 0.003 |